Saudi Arabian student Hibah Aldawsari's inspirational story of student life in the UK has resulted in her being named a runner-up in the regional finals of the UK's biggest international student competition.
Hibah, who is taking a Pharmacy PhD at the University of Strathclyde in Glasgow, was one of more than 1,200 students from 118 countries to enter the ninth annual International Student Awards – a major initiative from the British Council that shines the spotlight on international students and their contributions to life in the UK.
Hibah has been invited to celebrate her achievements at a national awards ceremony to be held in London on Wednesday, 13 April.
To enter the competition, international students were encouraged to write a personal ‘letter home’ in English, detailing the out-of-class achievements that help make their time in the UK so rewarding.
A judging panel met last month to discuss the merits of short-listed entries from the region. Hibah’s letter was judged to be one of Scotland’s best and she will receive a £100 prize.
Since arriving in Scotland three years ago, Hibah has combined her studies, which focus on the search for cancer treatments, with raising three children- and at the same time, her confidence and her relish for a challenge have grown.
She has won a series of awards, including a Strathclyde Institute of Pharmacy and Biomedical Sciences Research Excellence Award in 2010 and an Outstanding Poster award at the 2009 Saudi International Conference. She was also the main female speaker at the Saudi Day Exhibition in Glasgow in 2010.
In her letter, Hibah outlines how she has become more adept at facing up to challenges since arriving in Scotland- and how her experiences of dealing with the country’s different climate, particularly snow, have helped her.
Hibah said: “It’s a huge honour to receive this award from the British Council. My time in Scotland, and at Strathclyde, has been inspirational to me, personally and professionally, and has helped me to achieve a great deal- the interest I get in my research posters shows that I’m on the right path in my pharmacy projects.
“I’ve observed people going about their daily lives in the snow- they don’t let it deter them from walking or driving but make plans to deal with the potential risks it brings. In the same way, the advice and guidance I have received here have helped me to take on the challenges I face successfully.”
Hibah’s supervisor, Dr Christine Dufès, a Lecturer at the Strathclyde Institute of Pharmacy and Biomedical Sciences, said: “Hibah is an excellent student who has enjoyed well-deserved success at Strathclyde. The British Council award is the latest of many accolades she has received.”
Martin Davidson Chief Executive of the British Council, said the letters written by the entrants were both poignant and inspiring.
“The students have immersed themselves in life in the UK and are making a huge contribution not just to their campuses but to the wider community. The British Council is delighted to recognise their considerable achievements.”
The Strathclyde Institute of Pharmacy and Biomedical Sciences is currently the subject of an £8 million fundraising campaign for a £36 million new building to expand and enhance its work in developing new medicines for diseases including cancer, heart disease, infectious diseases and schizophrenia.
April 23rd, 2011, 03:16 PM
Hibah has been invited to celebrate her achievements at a national awards ceremony to be held in London on Wednesday, 13 April.
To enter the competition, international students were encouraged to write a personal ‘letter home’ in English, detailing the out-of-class achievements that help make their time in the UK so rewarding.
A judging panel met last month to discuss the merits of short-listed entries from the region. Hibah’s letter was judged to be one of Scotland’s best and she will receive a £100 prize.
Since arriving in Scotland three years ago, Hibah has combined her studies, which focus on the search for cancer treatments, with raising three children- and at the same time, her confidence and her relish for a challenge have grown.
She has won a series of awards, including a Strathclyde Institute of Pharmacy and Biomedical Sciences Research Excellence Award in 2010 and an Outstanding Poster award at the 2009 Saudi International Conference. She was also the main female speaker at the Saudi Day Exhibition in Glasgow in 2010.
In her letter, Hibah outlines how she has become more adept at facing up to challenges since arriving in Scotland- and how her experiences of dealing with the country’s different climate, particularly snow, have helped her.
Hibah said: “It’s a huge honour to receive this award from the British Council. My time in Scotland, and at Strathclyde, has been inspirational to me, personally and professionally, and has helped me to achieve a great deal- the interest I get in my research posters shows that I’m on the right path in my pharmacy projects.
“I’ve observed people going about their daily lives in the snow- they don’t let it deter them from walking or driving but make plans to deal with the potential risks it brings. In the same way, the advice and guidance I have received here have helped me to take on the challenges I face successfully.”
Hibah’s supervisor, Dr Christine Dufès, a Lecturer at the Strathclyde Institute of Pharmacy and Biomedical Sciences, said: “Hibah is an excellent student who has enjoyed well-deserved success at Strathclyde. The British Council award is the latest of many accolades she has received.”
Martin Davidson Chief Executive of the British Council, said the letters written by the entrants were both poignant and inspiring.
“The students have immersed themselves in life in the UK and are making a huge contribution not just to their campuses but to the wider community. The British Council is delighted to recognise their considerable achievements.”
The Strathclyde Institute of Pharmacy and Biomedical Sciences is currently the subject of an £8 million fundraising campaign for a £36 million new building to expand and enhance its work in developing new medicines for diseases including cancer, heart disease, infectious diseases and schizophrenia.